Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent-Reference-Cited by-同舟云学术

Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent

Published:2007-12 Issue:6 Volume:2 Page:583-590
ISSN:1746-0913
Container-title:Future Microbiology
language:en
Short-container-title:Future Microbiology

Author:

Aslam Saima¹,Musher Daniel M²

Affiliation:

1. Michael E DeBakey VA Medical Center, Section of Infectious Diseases, Room 4B-370, 2002 Holcombe Blvd, Houston, TX 77030, USA and, Baylor College of Medicine, Section of Infectious Diseases, Houston, TX, USA.

2. Michael E DeBakey VA Medical Center and, Baylor College of Medicine, Section of Infectious Diseases, Houston, TX, USA.

Abstract

Nitazoxanide is a new compound with broad-spectrum activity against numerous intestinal protozoa, helminths and anaerobic bacteria. It is approved for the treatment of diseases caused by Giardia intestinalis and Cryptosporidium species. The drug is well tolerated, with few side effects and requires a short course of treatment. Further investigations regarding its use in patients with AIDS is needed. Nitazoxanide represents a significant advance in the treatment of intestinal parasitic infections worldwide.

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/17460913.2.6.583

Reference35 articles.

1. Nitazoxanide: A New Thiazolide Antiparasitic Agent

2. Nitazoxanide for the Treatment of Clostridium difficile Colitis

3. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide

4. In Vitro and In Vivo Activities of Nitazoxanide against Clostridium difficile

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atazanavir/Ritonavir Increased Tizoxanide Exposure from Oral Nitazoxanide through Pharmacokinetic Interaction in Healthy Volunteers;Future Pharmacology;2024-02-22

2. Atazanavir/ritonavir increased tizoxanide exposure from oral nitazoxanide through pharmacokinetic interaction in healthy volunteers;2023-09-22

3. Targeting mycobacterial membranes and membrane proteins: Progress and limitations;Bioorganic & Medicinal Chemistry;2023-03

4. Synthesis and antiplasmodial assessment of nitazoxanide and analogs as new antimalarial candidates;Medicinal Chemistry Research;2022-01-28

5. The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum;Infection and Drug Resistance;2022-01